At a glance
ClinicalIndex Comparison RecordN/ACompleted· 22 enrolled
Drug / intervention
Asymmetric STN-DBSother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Single-center, Randomized, Double-blinded, Double-crossover Trial of Asymmetric Subthalamic Deep Brain Stimulation for Axial Motor Dysfunction in Parkinson's Disease
In Brief
A clinical study evaluating Asymmetric STN-DBS for Parkinson Disease. Completed, enrolled 22 participants across 1 site.
Detailed Summary
This single-center, randomized, quadruple-blinded, double-crossover comparative efficacy trial will study the effects of unilateral 50% voltage reduction in axial motor dysfunction for patients with Parkinson's disease that develop treatment-resistant postural stability gait dysfunction after bilateral subthalamic nucleus deep brain stimulation surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsParkinson Disease
CountriesCanada
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedMar 2018
Enrollment StartMar 2018
Primary CompletionApr 2019
TodayJul 2026
First PostedMar 12, 2018
Enrollment StartMar 14, 2018
Primary CompletionApr 15, 2019
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 8.3 years ago
Interventions
Asymmetric STN-DBSother
Asymmetric deep brain stimulation